ALIPAY+
1.2.2023 03:28:40 CET | Business Wire | Press release
Alipay+ has further strengthened its partnership with Asia’s largest food delivery platform, foodpanda, to Malaysia. Through this partnership, foodpanda Malaysia’s customers can now enjoy convenient food and grocery deliveries by paying through Touch ’n Go eWallet, one of the leading mobile wallets in Malaysia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005758/en/
Alipay+ has further strengthened its partnership with Asia’s largest food delivery platform, foodpanda, to Malaysia.
With contactless payments becoming more prevalent over the past few years, users of Touch ’n Go eWallet are now able to purchase food and daily essentials through foodpanda Malaysia, the country’s leading quick commerce delivery platform. Customers can also enjoy instant cash discount at checkout via Touch ‘n Go eWallet when placing orders on foodpanda.
“foodpanda Malaysia is committed to providing our customers with the convenience of having their food and daily essentials delivered right to their doorstep. We strive to be 1% better each time and add value to our customer’s experience. This time, it is to give them more options in payment methods,” said foodpanda Malaysia Chief Executive Officer Sayantan Das.
“We are proud to be partnering with Alipay+ and TNG Digital to enable the usage of Touch ’n Go eWallet on our platform. Leveraging our synergies as the leading quick commerce platform and the largest eWallet provider in the country, we are happy to play our role in encouraging the adoption of digital payment for the convenience and safety of millions of our merchants, riders and customers,” he added.
The gross merchandise value (GMV) of the on-demand food delivery market in Southeast Asia is expected to reach US$49.7 billion by 2030, growing at a compound annual growth rate of 14.1%, according to a 2022 report from research firm Frost & Sullivan. The GMV was estimated to be at US$15.2 billion in 2021, it said.
foodpanda Malaysia’s latest partnership with Touch ’n Go eWallet will tap into the eWallet’s more than 18 million registered users.
Commenting on the collaboration, Alan Ni, Chief Executive Officer of TNG Digital Sdn Bhd said, “We are very excited to partner with foodpanda to give our users access to a seamless and convenient delivery experience in Malaysia.
“Through Touch ’n Go eWallet, our users will be able to make payments for their orders with peace of mind knowing that their transactions are safe and secure,” he added.
Introduced by Ant Group in 2020, Alipay+ is a suite of cross-border digital payment, marketing and merchant digitization solutions connecting global brands with mobile-savvy consumers worldwide. Currently, 16 global e-wallet partners backed by Alipay+ have covered more than 1.3 billion digital-savvy consumers, mostly in Southeast Asia.
Alipay+ Rewards is a new digital marketing platform developed by Alipay+ and partner e-wallets to help global brands better engage with consumers worldwide by offering incentives and exclusive services.
Malaysia is the fifth major market in Asia where Alipay+ and foodpanda have collaborated to provide services with leading local mobile wallets in the region. Prior to this latest partnership in Malaysia, other Alipay+ partner e-wallets, including GCash in the Philippines, TrueMoney in Thailand, bKash in Bangladesh and AlipayHK in Hong Kong SAR, China, have already supported payments on their respective local foodpanda platforms.
Jing Yin, General Manager of Acquiring Service and Global Strategic Accounts of Ant Group, said: “Alipay+ is committed to helping merchants reach more than 1 billion global consumers and ensure easy and smooth payments of our e-wallet partners when consumers place orders on each platform.
“We are excited to offer payment and marketing solutions to foodpanda Malaysia through the Touch ’n Go eWallet, and we are looking forward to partnering with foodpanda in more markets by bringing more designated benefits with our local e-wallet partners in the future.”
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing solutions offered by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
About foodpanda
foodpanda is a leading delivery platform in Asia Pacific dedicated to bringing consumers a wide range of food, groceries and more, quickly and conveniently. Powered by technology and operational excellence, foodpanda is spearheading the growth of quick-commerce (q-commerce) across the region with its network of retail partners, as well as pandamart cloud stores to provide more on-demand options beyond the millions of food delivery options. foodpanda operates in more than 300 cities across 11 markets in Asia Pacific - Singapore, Hong Kong, Thailand, Malaysia, Pakistan, Taiwan, Philippines, Bangladesh, Laos, Cambodia, and Myanmar. foodpanda is a subsidiary of Delivery Hero, a global leader in the food delivery industry. For more information, visit www.foodpanda.com.
About TNG Digital Sdn Bhd
TNG Digital Sdn Bhd (“TNGD”) was founded by Touch ‘n Go Sdn Bhd and Ant Group (“Ant”), parent company of Alipay, China’s largest digital payments platform. Established in 2017, TNGD is the owner and operator of Touch ‘n Go eWallet, Malaysia’s number one eWallet company, with more than 18 million registered users and over 1.2 million merchant touch points including DuitNow QR. Combining Touch ‘n Go’s strong domestic brand, dominance in toll, transit and parking use cases and nationwide user base, together with Ant’s deep domain expertise and leading the development of open platforms for technology-driven inclusive financial services, the Touch ‘n Go eWallet provides financial services and payments services to both retail users and small to mid-sized businesses, across physical and online infrastructure. For more information, please visit www.touchngo.com.my.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005758/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom